EZH2 and central nervous system cancer: Both, the specific EZH2 knockdown by siRNA and the treatment with 5 μM DZNep led to a strong reduction of the trimethylation of H3K27 in human U87MG glioma cells confirming the inhibition of the EZH2 histone methylation activity (Figure 2G).